Robert M. Strauss, M.D.


Physicians

Work History:

	1998~	Northwest Georgia Gastroenterology Associates, P.C. 790 Church Street Extension, Suite 500 Marietta, GA 30060
	1996~1998	Associate Professor of Medicine, Emory University School of Medicine, Atlanta, GA
	1994~1998	Chief, Gastrointestinal Oncology, The Emory Clinic and Emory University Hospital
	1990~1996	Assistant Professor of Medicine, Emory University School of Medicine, Atlanta, GA

Education and Training:

	1976	B.S. - Escuela Secundaria y Preparatoria de la Ciudad de Mexico, Mexico City, MEX
	1983	M.D. - Universidad Nacional Autonoma de Mexico, Mexico City, MEX
	1983~1984	Intern in Medicine Emory University Affiliated Hospitals Atlanta, GA
	1984~1986	Resident in Medicine Emory University Affiliated Hospitals Atlanta, GA
	1986~1990	Research Fellow in Medicine Harvard Medical School Cambridge, MA
	1986~1990	Clinical and Research Fellow in Medicine, Massachusetts General Hospital Boston, MA

Board Certification:

	1986	Internal Medicine - American Board of Internal Medicine
	1989	Gastroenterology - American Board of Internal Medicine

Association Memberships:

	American Association for the Study of Liver Diseases
	American College of Gastroenterology
	American College of Physicians
	American Gastroenterology Association
	American Medical Association
	AMPAC
	Bockus International Society of Gastroenterology
	Cobb County Medical Society
	Crohn’s and Colitis Foundation of America
	GAMPAC
	Georgia Gastroenterology and Endoscopy Society
	Georgia Medical Society
	Medical Association of Georgia
	Southern Medical Association

Publications:

	Manuscripts
	(1)	Uribe M, Ballesteros A, Strauss RM, Rosales J, Villalobos A, Briones A, Garcia Ramos G. Successful administration of metoclopramide for the treatment of nausea in patients with advanced liver disease. Gastroenterology. 1985; 88:757-62.
	(2)	Parsonnet J, Welch K, Compton C, Strauss R, Wang T, Kelsey P, Ferraro MJ. Simple microbiologic detection of campylobacter pylori. J Clin Microbiol. 1988; 26:948-49.
	(3)	Gattoni-Celli S, Willett CG, Rhoads DB, Simon B, Strauss RM, Kirsch K, Isselbacher KJ. Partial suppression of anchorage-independent growth and tumorigenicity in immuno-deficient mice by transinfection of the H2 class I gene H-2LS into a human cancer cell line (HCT). Proc. Natl. Acad. Sci. 1988; 85:8543-47.
	(4)	Gattoni-Celli S, Strauss RM, Willet CG, Pozatti R, Isselbacher KJ. Modulation of the transformed and neoplastic phenotype of rat fibroblast by MHC-1 gene expression. Cancer Res 1989; 49:3392-3395.
	(5)	Strauss RM, Wang TC, Kelsey PG, Compton CC, Ferraro M-J, Perez-Perez G, Parsonnet J, Blazer MJ. Association of Helicobacter pylori infection with dyspeptic symptoms in patients undergoing gastroduodenoscopy. Am J. Med. 1990; 89:464-69.
	(6)	Hsu DW, Hedley-Whyte ET, Hooi SC, Strauss RM, Kaplan LM. Coexpression of galanin and adrenocoencotropic hormone in human pituitary gland and adenomas. Am J. Pathol. 1991; 138:897-909.
	(7)	Strauss RM. Examination of the gastrointestinal and hepatobiliary system: The importance of initial screening. The Emory University Journal of Medicine. 1992; 6:8-16.
	(8)	Magod ME, Strauss RM, Waring JP. Esophageal variceal ligation and the optimal interval for endoscopic variceal ligation with low-dose sclerotherapy. Gastrointestinal Endosc. 1993; 39:211-12.
	(9)	Redvanly RD, Chezmar JL, Strauss RM, Galloway JR, Boyer TD, Bernardino ME. Safety of high dose percutaneous ethanol ablation therapy, for malignant hepatic tumors. Radiology 1993; 188:283-85.
	(10)	Strauss RM, Martin L, Kaufman S, Boyer TB. Transjugular intrahepatic systemic shunt (TIPS) for the management of symptomatic cirrhotic hydrothoras. Am J. Gastroenterol 1994; 89:1520-22.
	(11)	Strauss RM, Boyer TD. Hepatic Hydrothorax. Seminars in Liver Dis 1997; 17:227-232.
	(12)	Farrel GC, Bacon BR, Goldin RD, and the Clinical Advisory Group for the Hepatitis C Comparative Study. Lymphoblastoid interferon improves the long term response to a six-month course of treatment in chronic hepatitis C compared with recombinant interfero-a2b. Results of an international randomized controlled trial. Hepatology 1998.
	(13)	Vassilopoulos D, Camisa D, Strauss RM. Selected drug complications and treatment conflicts in the presence of coexistent diseases. Rheumatic Disease Clinics of N. America. 1999; 23:745-777.
	Book Chapters:
	(1)	Strauss RM. Polyposis Syndromes and Colon Cancer. In: Comprehensive Board Review in Internal Medicine: Department of Medicine, Emory University School of Medicine. August, 1991; Vol 1, Section 2, pp 1-18.
	(2)	Strauss RM, Boyer TD. Diseases of the Liver. In: Barondess JA., Carpenter CCJ. (eds.) Differential Diagnosis Lea & Febiger, Philadelphia Hong Kong, London, Munich, Sydney, Tokyo. 1994; pp 392-459.
	(3)	Strauss RM. Peptic Ulcer Disease. In: Lubin M, Walker, HK, Smith, R (eds.) Medical Management of the Surgical Patient, 3rd edition. J.B. Lippincott Company. Philadelphia. 1995; pp 159-164.
	(4)	Strauss RM, Dienstag JL. Ascites and Its Complications. In: Morris PJ, Malt RA, (eds.) Oxford Textbook of Surgery. First Edition.
	(5)	Strauss RM. Clinical Aspects of Hepatocellular Carcinoma. In: Rustgi, AK (ed.) Gastrointestinal Cancers: Biology, Diagnosis and Therapy. Raven Press, New York. 1995; pp 600-625.
	(6)	Strauss RM, Boyer TD. Diagnosis and Management of Cirrhotic Ascites. In: Zakim D, Boyer TD (eds.) Hepatology, A Textbook of Liver Disease. Third Edition. W.B. Saunders Co. Philadelphia. 1996; pp 764-788.
	(7)	Strauss RM, Dienstag JL. Ascites and Its Complications, in: Morris PJ, Wood WC. Oxford Textbook of Surgery. 2nd Edition. Oxford University Press. Oxford and New York. 2000; pp 1753-1761.
	Books:
		Gitlin N., Strauss RM, eds. Atlas of Clinical Hepatology. W.B. Saunders Co. Philadelphia, 1995.

Personal:

	Married
	Two Children